Literature DB >> 7199562

A comparison of in vitro- and in vivo-phosphorylated neurofilament polypeptides.

J P Julien, W E Mushynski.   

Abstract

Neurofilament polypeptides phosphorylated in vitro by incubation of neurofilament-enriched preparations from rat CNS with [gamma-32P]ATP were compared with the corresponding polypeptides labeled in vivo by injection of 32Pi into the lateral ventricles of rats. Autoradiography of sodium dodecyl sulfate (SDS)-polyacrylamide gels revealed that the major phosphorylated species in both preparations were the three neurofilament subunits, which have molecular weights of 200K, 145K, and 68K. However, the relative levels of 32P detected in the three in vitro-labeled subunits differed from the relative in vivo levels. The two larger neurofilament polypeptides displayed similar 32P isoprotein distribution patterns on two-dimensional gels, whereas additional isoproteins were seen in the in vitro-labeled 68K species. Limited proteolysis in SDS-polyacrylamide gels revealed the presence of common phosphopeptides in the corresponding pairs of in vitro- and in vivo-labeled subunits, but the in vivo-labeled 145K and in vitro-labeled 200K polypeptides contained additional digestion products. Two-dimensional peptide mapping of the 68K polypeptide digested with a mixture of trypsin and chymotrypsin indicated that this component was phosphorylated at a single, identical site, both in vivo and in vitro. These results indicate that the protein kinase that copurifies with neurofilament preparations may be involved in their in vivo phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7199562     DOI: 10.1111/j.1471-4159.1981.tb06330.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Interaction in vitro of the neurofilament triplet proteins from porcine spinal cord with natural RNA and DNA.

Authors:  P Traub; C E Vorgias; W J Nelson
Journal:  Mol Biol Rep       Date:  1985-04       Impact factor: 2.316

2.  Appearance and phosphorylation of the 210 kDalton neurofilament protein in newborn rat brain, spinal cord, and sciatic nerve.

Authors:  M J Noetzel; B I Roots; H C Agrawal
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

3.  Influence of the phosphorylation state of neurofilament proteins on the interactions between purified filaments in vitro.

Authors:  J Eyer; J F Leterrier
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

4.  Processing of neurofilament proteins from perikaryal to axonal type.

Authors:  I Toyoshima; A Yamamoto; M Satake
Journal:  Neurochem Res       Date:  1988-07       Impact factor: 3.996

5.  An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles.

Authors:  D Munoz-Garcia; W W Pendlebury; J B Kessler; D P Perl
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes.

Authors:  W G McLean; C Pekiner; N A Cullum; I F Casson
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

7.  A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo.

Authors:  A J Chapman; H E Farrell; J A Thomas; J M Papadimitriou; M J Garlepp; A A Scalzo; G R Shellam
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

8.  Neurofilament Phosphorylation during Development and Disease: Which Came First, the Phosphorylation or the Accumulation?

Authors:  Jeffrey M Dale; Michael L Garcia
Journal:  J Amino Acids       Date:  2012-04-18

9.  Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments.

Authors:  S E Lewis; R A Nixon
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.